<!doctype html><html><head><meta charset=utf-8><title>Melanoma is 1.4X more-likely if low Vitamin D – meta-analysis</title>
<link rel=stylesheet href="/css/main.css?v=1753303881"><link rel=stylesheet href="/css/pagination.css?v=1753303881"><link rel=stylesheet href=https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css><script src="/js/search-suggestions.js?v=1753303881"></script><script src="/js/search.js?v=1753303881"></script><script type=module>
        
        window.initPagefind = async function() {
            try {
                console.log('Loading Pagefind module...');
                window.pagefind = await import('/pagefind/pagefind.js');
                if (!window.pagefind) {
                    throw new Error('Failed to load Pagefind module - import returned empty result');
                }
                
                console.log('Initializing Pagefind...');
                const initResult = await window.pagefind.init();
                console.log('Pagefind loaded and initialized');
                
                
                if (window.searchInstance) {
                    console.log('Notifying Search instance of Pagefind initialization');
                    window.searchInstance.initializePagefind(window.pagefind);
                    console.log('Search instance successfully notified');
                } else {
                    console.warn('Search instance not found in global scope yet, but Pagefind is loaded');
                    
                }
            } catch (error) {
                console.error('CRITICAL ERROR: Failed to initialize Pagefind:', error);
                
                const errorDetails = error.stack || error.message || String(error);
                console.error('Error details:', errorDetails);
                
                
                const statusEl = document.querySelector('#search-status');
                const inputEl = document.querySelector('#search-input');
                
                if (statusEl) {
                    statusEl.textContent = 'Search unavailable: ' + error.message;
                    statusEl.style.display = 'block';
                    statusEl.style.color = 'red';
                }
                
                if (inputEl) {
                    inputEl.disabled = true;
                    inputEl.placeholder = 'Search unavailable';
                }
            }
        };
        
        
        window.pagefindInitialized = false;
        
        
        document.addEventListener('DOMContentLoaded', () => {
            console.log('DOM loaded, initializing Pagefind...');
            window.initPagefind();
        });
    </script></head><body><div class=top-nav><div class=home-icon><a href=/ title="Go to Home Page"><svg viewBox="0 0 576 512" width="28" height="28"><path d="M575.8 255.5c0 18-15 32.1-32 32.1h-32l.7 160.2c0 2.7-.2 5.4-.5 8.1V472c0 22.1-17.9 40-40 40H456c-1.1.0-2.2.0-3.3-.1-1.4.1-2.8.1-4.2.1H416 392c-22.1.0-40-17.9-40-40V448 384c0-17.7-14.3-32-32-32H256c-17.7.0-32 14.3-32 32v64 24c0 22.1-17.9 40-40 40H160 128.1c-1.5.0-3-.1-4.5-.2-1.2.1-2.4.2-3.6.2H104c-22.1.0-40-17.9-40-40V360c0-.9.0-1.9.1-2.8V287.6H32c-18 0-32-14-32-32.1.0-9 3-17 10-24L266.4 8c7-7 15-8 22-8s15 2 21 7L564.8 231.5c8 7 12 15 11 24z"/></svg></a></div><div class=search-container><div class=search-icon><i class="fas fa-search"></i></div><input type=text id=search-input placeholder=Search... disabled><div id=suggestions class=search-suggestions style=display:none></div><ul id=search-results style=display:none></ul><div id=search-results-panel class=search-results-panel><div class=results-header>Search Results</div><ul id=search-results-panel-list class=results-list></ul></div></div></div><div class=container><div class="content content-full-width" role=main><article><div class=scroll-nav-top><a href=javascript:void(0); id=scroll-to-bottom class=scroll-button aria-label="Scroll to bottom" onclick='return window.scrollTo({top:document.body.scrollHeight,behavior:"smooth"}),!1'><svg width="16" height="16" fill="currentcolor" viewBox="0 0 16 16"><path d="M8 4a.5.5.0 01.5.5v5.793l2.146-2.147a.5.5.0 01.708.708l-3 3a.5.5.0 01-.708.0l-3-3a.5.5.0 11.708-.708L7.5 10.293V4.5A.5.5.0 018 4z"/></svg>
<span>Scroll to Bottom</span></a></div><h1>Melanoma is 1.4X more-likely if low Vitamin D – meta-analysis</h1><time>May 18, 2023</time><div data-pagefind-body><nav id=TableOfContents><ul><li><ul><li><ul><li><a href=#vitamin-d-insufficiency-and-serum-levels-related-to-the-incidence-and-stage-of-cutaneous-melanoma-a-systematic-review-and-meta-analysis>Vitamin D insufficiency and serum levels related to the incidence and stage of cutaneous melanoma: a systematic review and meta-analysis</a></li></ul></li></ul></li></ul></nav><hr><h4 id=vitamin-d-insufficiency-and-serum-levels-related-to-the-incidence-and-stage-of-cutaneous-melanoma-a-systematic-review-and-meta-analysis>Vitamin D insufficiency and serum levels related to the incidence and stage of cutaneous melanoma: a systematic review and meta-analysis</h4><p>Melanoma Res . 2023 May 18. <a href=https://doi.org/10.1097/CMR.0000000000000897>doi: 10.1097/CMR.0000000000000897</a> PDF is behind a $51 paywall</p><p>Richard A Shellenberger 1, Sunaina Gowda 1, Heidi Kurn 1, Jeremy Albright 2, MacKenzie H Mayo 1</p><p>Cutaneous melanoma (CM) is the deadliest skin cancer, and vitamin D insufficiency has been suggested as a risk factor. We evaluated the relationship between both vitamin D insufficiency and 25-hydroxy vitamin D levels with the incidence and stage of CM. Five databases were searched from inception until 11 July 2022. Inclusion criteria were cohort and case-control studies that reported mean 25-hydroxy vitamin D levels or the presence of vitamin D insufficiency in CM patients and compared with healthy controls; or those that reported vitamin D insufficiency and Breslow tumor depth or the development of metastasis in CM.</p><p>Fourteen studies were included in the analysis.</p><p>Statistically significant relationships were found between</p><ul><li><p>vitamin D level &lt;20 ng/dl and incidence of CM <span>[pooled <strong>RR 1.45</strong>, 95% confidence interval (CI) 1.04-2.02]</span>;</p></li><li><p>lower mean vitamin D level and Breslow depth >1 mm (SMD 0.19, 95% CI 0.11-0.28); and</p></li><li><p>vitamin D level >20 ng/dl and Breslow depth &lt;1 mm (pooled RR 0.69, 95% CI 0.58-0.82).</p></li></ul><p>Statistical significance was not found in the relationships between vitamin D levels and the presence of metastasis (pooled SMD -0.13, 95% CI, -0.38 to 0.12); or mean vitamin D level and the incidence of CM (pooled SMD -0.39, 95% CI, -0.80 to 0.01).</p><p>We identified an association of increased incidence of CM and vitamin D insufficiency, as well as less favorable Breslow tumor depth with lower levels of vitamin D and the presence of vitamin D insufficiency.</p><hr><h5 id=references>References</h5><ol><li><p>Institute. USDoHHSNIoHNC. Surveillance, Epidemiology, and End Results Program. Cancer Stat Facts: Common Cancer Sites. Published 2022. <a href=https://seer.cancer.gov/statfacts/html/common.html>https://seer.cancer.gov/statfacts/html/common.html</a>. <span>[Accessed 11 April 2022]</span>.</p></li><li><p>Institute USDoHHSNIOHNC. Surveillance, Epidemiology, and End Results Program. Cancer Stat Facts: Melanoma of the Skin. Published 2022. <a href=https://seer.cancer.gov/statfacts/html/melan.html>https://seer.cancer.gov/statfacts/html/melan.html</a>. <span>[Accessed 26 March 2022]</span>.</p></li><li><p>Oncology ASoC. Types of Cancer. Melanoma Guide. Statistics. Published 2022. <a href="https://www.cancer.net/cancer-types/melanoma/statistics#:~:text=Melanoma">https://www.cancer.net/cancer-types/melanoma/statistics#:~:text=Melanoma</a>&mldr;. <span>[Accessed 24 March 2022]</span>.</p></li><li><p>Society AC. Cancer A-Z. Melanoma Skin Cancer. Causes, Risk Factors, and Prevention. Published 2022. <a href=https://www.cancer.org/cancer/melanoma-skin-cancer/causes-risks-preventi>https://www.cancer.org/cancer/melanoma-skin-cancer/causes-risks-preventi</a>&mldr;. <span>[Accessed 22 March 2022]</span>.</p></li><li><p>Paolino G, Moliterni E, Didona D, Garelli V, Corsetti P, Lopez T, et al. Clinicopathological features, vitamin D serological levels and prognosis in cutaneous melanoma of shield-sites: an update. Med Oncol 2015; 32:451.</p></li><li><p>Gandini S, Boniol M, Haukka J, Byrnes G, Cox B, Sneyd MJ, et al. Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. Int J Cancer 2011; 128:1414–1424.</p></li><li><p>Krishnan AV, Feldman D. Mechanisms of the anti-cancer and anti-inflammatory actions of vitamin D. Annu Rev Pharmacol Toxicol 2011; 51:311–336.</p></li><li><p>Pinczewski J, Slominski A. The potential role of vitamin D in the progression of benign and malignant melanocytic neoplasms. Exp Dermatol 2010; 19:860–864.</p></li><li><p>Slominski AT, Brożyna AA, Zmijewski MA, Jóźwicki W, Jetten AM, Mason RS, et al. Vitamin D signaling and melanoma: role of vitamin D and its receptors in melanoma progression and management. Lab Invest 2017; 97:706–724.</p></li><li><p>Bade B, Zdebik A, Wagenpfeil S, Gräber S, Geisel J, Vogt T, et al. Low serum 25-hydroxyvitamin d concentrations are associated with increased risk for melanoma and unfavourable prognosis. PLoS One 2014; 9:e112863.</p></li><li><p>Cattaruzza MS, Pisani D, Fidanza L, Gandini S, Marmo G, Narcisi A, et al. 25-Hydroxyvitamin D serum levels and melanoma risk: a case-control study and evidence synthesis of clinical epidemiological studies. Eur J Cancer Prev 2019; 28:203–211.</p></li><li><p>Davies JR, Chang YM, Snowden H, Chan M, Leake S, Karpavicius B, et al. The determinants of serum vitamin D levels in participants in a melanoma case-control study living in a temperate climate. Cancer Causes Control 2011; 22:1471–1482.</p></li><li><p>Ene CD, Anghel AE, Neagu M, Nicolae I. 25-OH Vitamin D and interleukin-8: emerging biomarkers in cutaneous melanoma development and progression. Mediators Inflamm 2015; 2015:904876.</p></li><li><p>Lombardo M, Vigezzi A, Ietto G, Franchi C, Iori V, Masci F, et al. Role of vitamin D serum levels in prevention of primary and recurrent melanoma. Sci Rep 2021; 11:5815.</p></li><li><p>Navarrete-Dechent C, Del Puerto C, Molgó M, González S, Pérez-Mateluna G, Uribe P, et al. Circulating vitamin D-binding protein and free 25-hydroxyvitamin D concentrations in patients with melanoma: a case-control study. J Am Acad Dermatol 2017; 77:575–577.</p></li><li><p>Nürnberg B, Gräber S, Gärtner B, Geisel J, Pföhler C, Schadendorf D, et al. Reduced serum 25-hydroxyvitamin D levels in stage IV melanoma patients. Anticancer Res 2009; 29:3669–3674.</p></li><li><p>Stenehjem JS, Støer NC, Ghiasvand R, Grimsrud TK, Babigumira R, Rees JR, et al. Prediagnostic serum 25-hydroxyvitamin D and melanoma risk. Sci Rep 2020; 10:20129.</p></li><li><p>Befon A, Katoulis AC, Georgala S, Katsampas A, Chardalia V, Melpidou A, et al. Serum Total 25-Hydroxyvitamin D levels in patients with cutaneous malignant melanoma: a case-control study in a low-risk Southern European Population. Dermatol Pract Concept 2020; 10:e2020010.</p></li><li><p>Timerman D, McEnery-Stonelake M, Joyce CJ, Nambudiri VE, Hodi FS, Claus EB, et al. Vitamin D deficiency is associated with a worse prognosis in metastatic melanoma. Oncotarget 2017; 8:6873–6882.</p></li><li><p>Gambichler T, Bindsteiner M, Höxtermann S, Kreuter A. Serum 25-hydroxyvitamin D serum levels in a large German cohort of patients with melanoma. Br J Dermatol 2013; 168:625–628.</p></li><li><p>Newton-Bishop JA, Beswick S, Randerson-Moor J, Chang YM, Affleck P, Elliott F, et al. Serum 25-hydroxyvitamin D3 levels are associated with Breslow thickness at presentation and survival from melanoma. J Clin Oncol 2009; 27:5439–5444.</p></li><li><p>Randerson-Moor JA, Taylor JC, Elliott F, Chang Y-M, Beswick S, Kukalizch K, et al. <strong>Vitamin D receptor</strong> gene polymorphisms, serum 25-hydroxyvitamin D levels, and melanoma: UK case-control comparisons and a meta-analysis of published VDR data. Eur J Cancer 2009; 45:3271–3281.</p></li><li><p>Lim A, Shayan R, Varigos G. High serum vitamin D level correlates with better prognostic indicators in primary melanoma: a pilot study. Australas J Dermatol 2018; 59:182–187.</p></li><li><p>Lipplaa A, Fernandes R, Marshall A, Lorigan P, Dunn J, Myers KA, et al. 25-hydroxyvitamin D serum levels in patients with high risk resected melanoma treated in an adjuvant bevacizumab trial. Br J Cancer 2018; 119:793–800.</p></li><li><p>Caini S, Boniol M, Tosti G, Magi S, Medri M, Stanganelli I, et al. Vitamin D and melanoma and non-melanoma skin cancer risk and prognosis: a comprehensive review and meta-analysis. Eur J Cancer 2014; 50:2649–2658.</p></li><li><p>Tsai TY, Kuo CY, Huang YC. The association between serum vitamin D level and risk and prognosis of melanoma: a systematic review and meta-analysis. J Eur Acad Dermatol Venereol 2020; 34:1722–1729.</p></li><li><p>Piotrowska A, Wierzbicka J, Żmijewski MA. Vitamin D in the skin physiology and pathology. Acta Biochim Pol 2016; 63:17–29.</p></li><li><p>Mahamat-Saleh Y, Aune D, Schlesinger S. 25-Hydroxyvitamin D status, vitamin D intake, and skin cancer risk: a systematic review and dose-response meta-analysis of prospective studies. Sci Rep 2020; 10:13151.</p></li><li><p>Afzal S, Nordestgaard BG, Bojesen SE. Plasma 25-hydroxyvitamin D and risk of non-melanoma and melanoma skin cancer: a prospective cohort study. J Invest Dermatol 2013; 133:629–636.</p></li><li><p>Saiag P, Aegerter P, Vitoux D, Lebbé C, Wolkenstein P, Dupin N, et al. Prognostic value of 25-hydroxyvitamin D3 levels at diagnosis and during follow-up in melanoma patients. J Natl Cancer Inst 2015; 107:djv264.</p></li><li><p>Major JM, Kiruthu C, Weinstein SJ, Horst RL, Snyder K, Virtamo J, et al. Pre-diagnostic circulating vitamin D and risk of melanoma in men. PLoS One 2012; 7:e35112.</p></li><li><p>Oliveira Filho RS, Oliveira DA, Martinho VA, Antoneli CB, Marcussi LA, Ferreira CE. Serum level of vitamin D3 in cutaneous melanoma. Einstein (Sao Paulo) 2014; 12:473–476.</p></li><li><p>Skaaby T, Husemoen LL, Thuesen BH, Pisinger C, Jørgensen T, Roswall N, et al. Prospective population-based study of the association between serum 25-hydroxyvitamin-D levels and the incidence of specific types of cancer. Cancer Epidemiol Biomarkers Prev 2014; 23:1220–1229.</p></li><li><p>Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009; 339:b2535.</p></li><li><p>Bouillon R, Carmeliet G. Vitamin D insufficiency: definition, diagnosis and management. Best Pract Res Clin Endocrinol Metab 2018; 32:669–684.</p></li><li><p>Wells GA, Shea B, O’Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. Published 2014. <a href=https://www.ohri.ca/programs/clinical_epidemiology/oxford.asp>www.ohri.ca/programs/clinical_epidemiology/oxford.asp</a>. <span>[Accessed 24 October 2018]</span>.</p></li><li><p>Murad MH. Clinical practice guidelines: a primer on development and dissemination. Mayo Clin Proc 2017; 92:423–433.</p></li><li><p>Evans SR, Houghton AM, Schumaker L, Brenner RV, Buras RR, Davoodi F, et al. <strong>Vitamin D receptor</strong> and growth inhibition by 1,25-dihydroxyvitamin D3 in human malignant melanoma cell lines. J Surg Res 1996; 61:127–133.</p></li><li><p>Osborne JE, Hutchinson PE. Vitamin D and systemic cancer: is this relevant to malignant melanoma? Br J Dermatol 2002; 147:197–213.</p></li><li><p>Muralidhar S, Filia A, Nsengimana J, Poźniak J, O&rsquo;Shea SJ, Diaz JM, et al. Vitamin D- <strong>VDR</strong> signaling inhibits Wnt/β-Catenin-mediated melanoma progression and promotes antitumor immunity. Cancer Res 2019; 79:5986–5998.</p></li><li><p>Arnold M, Singh D, Laversanne M, Vignat J, Vaccarella S, Meheus F, et al. Global Burden of cutaneous melanoma in 2020 and projections to 2040. JAMA Dermatol 2022; 158:495–503.</p></li></ol></div><hr class=tag-separator><div class=tags><span>Tags: </span><a href=/tags/autoimmune.html><span class=tag>autoimmune</span></a>
<a href=/tags/cancer.html><span class=tag>cancer</span></a>
<a href=/tags/cancer-in-vdr.html><span class=tag>cancer in VDR</span></a>
<a href=/tags/genetics.html><span class=tag>genetics</span></a>
<a href=/tags/high-dose.html><span class=tag>high dose</span></a>
<a href=/tags/immunity.html><span class=tag>immunity</span></a>
<a href=/tags/intervention.html><span class=tag>intervention</span></a>
<a href=/tags/melanoma.html><span class=tag>melanoma</span></a>
<a href=/tags/meta-analysis.html><span class=tag>Meta-analysis</span></a>
<a href=/tags/multiple-sclerosis.html><span class=tag>multiple sclerosis</span></a>
<a href=/tags/prostate-cancer.html><span class=tag>prostate cancer</span></a>
<a href=/tags/skin-cancer.html><span class=tag>skin cancer</span></a>
<a href=/tags/skin-cancer.html><span class=tag>Skin Cancer</span></a>
<a href=/tags/therapeutic-intervention.html><span class=tag>therapeutic intervention</span></a>
<a href=/tags/vitamin-d.html><span class=tag>vitamin d</span></a>
<a href=/tags/vitamin-d-blood-test.html><span class=tag>vitamin d blood test</span></a>
<a href=/tags/vitamin-d-receptor.html><span class=tag>vitamin d receptor</span></a></div><div data-pagefind-meta=tags hidden>autoimmune, cancer, cancer in VDR, genetics, high dose, immunity, intervention, melanoma, Meta-analysis, multiple sclerosis, prostate cancer, skin cancer, Skin Cancer, therapeutic intervention, vitamin d, vitamin d blood test, vitamin d receptor</div><div class=scroll-nav-bottom id=article-bottom><a href=javascript:void(0); id=scroll-to-top class=scroll-button aria-label="Scroll to top" onclick='return window.scrollTo({top:0,behavior:"smooth"}),!1'><svg width="16" height="16" fill="currentcolor" viewBox="0 0 16 16"><path d="M8 12a.5.5.0 00.5-.5V5.707l2.146 2.147a.5.5.0 00.708-.708l-3-3a.5.5.0 00-.708.0l-3 3a.5.5.0 10.708.708L7.5 5.707V11.5a.5.5.0 00.5.5z"/></svg>
<span>Back to Top</span></a></div></article></div></div><script src="/js/toc-sanitizer.js?v=1753303881"></script><script src="/js/tiki-redirects.js?v=1753303881"></script><script src="/js/lightspa.js?v=1753303881"></script><script>const spa=new LightSPA({mainContentSelector:'[role="main"]',navigationSelector:"[data-spa-nav]"});window.search=new Search({documentsUrl:"/search/search_documents.json.gz?v=1753303881",indexUrl:"/search/search_index.json.gz?v=1753303881"}),document.addEventListener("DOMContentLoaded",function(){function e(e){var t=e.querySelector(".category-expander"),n=e.querySelector(".subcategory-list");e.classList.contains("collapsed")?(e.classList.remove("collapsed"),e.classList.add("expanded"),t.textContent="-",n.style.display="block"):(e.classList.remove("expanded"),e.classList.add("collapsed"),t.textContent="+",n.style.display="none")}document.querySelectorAll(".category-expander").forEach(function(t){t.addEventListener("click",function(t){t.stopPropagation();var n=this.closest(".top-level-category");e(n)})}),document.querySelectorAll(".category-name").forEach(function(t){t.addEventListener("click",function(t){t.stopPropagation();var n=this.closest(".top-level-category");e(n)})})})</script><script src="/js/scroll-buttons.js?v=1753303881"></script></body></html>